Health insurance coverage and cost barriers to needed medical care among U.S. adult cancer survivors age<65 years

Cancer
Susan A SabatinoLori A Pollack

Abstract

The health insurance and cost barriers to care among cancer survivors age <65 years were examined. Using the 1998 and 2000 National Health Interview Survey, survivors ages 18 to 64 years (n=1718) were compared with similarly aged adults without cancer (n=50,276) to examine health insurance and reported delayed/missed needed medical care within the previous year because of cost. Findings were initially adjusted for age, sex, race, and ethnicity, and further adjusted for employment, income, health status, marital status, and region. Before adjustment, survivors were less likely to be uninsured (12.4% vs. 18.0%) and more likely to have public insurance (11.2% vs. 6.2%). After initial adjustment, survivors were as likely to lack insurance, less likely to have private insurance, and more likely to have public insurance. After further adjusting, differences in being uninsured were found to be small, differences in having private insurance were eliminated, and differences in having public insurance were reduced. Survivors most likely to lack insurance were younger, female, African-American, or lower income. Survivors, particularly uninsured or publicly insured survivors, were more likely to delay/miss care because of cost. Overall, 20...Continue Reading

References

Mar 1, 1989·American Journal of Public Health·S Greenland
Nov 1, 1995·Medical and Pediatric Oncology·J C VannS H Gold
Mar 15, 1995·Statistics in Medicine·S L Botman, S S Jack
Jul 4, 1998·Cancer Practice·J J GuidryR J Winn
Sep 2, 1999·Journal of the National Cancer Institute·M HewittS Devesa
Jun 24, 2000·JAMA : the Journal of the American Medical Association·H G WelchS Woloshin
Oct 24, 2000·JAMA : the Journal of the American Medical Association·J Z AyanianA M Zaslavsky
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A RechtUNKNOWN American Society of Clinical Oncology
Sep 7, 2002·Women & Health·Thomas N ChirikosPaul B Jacobsen
Nov 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maria Hewitt, Julia H Rowland
Feb 1, 2003·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Maria HewittRosemary Yancik
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleJane C Weeks
Oct 7, 2003·Health Affairs·Kenneth E Thorpe, David Howard
Dec 24, 2003·Cancer·Pamela N SchultzRena Vassilopoulou-Sellin
Sep 2, 2004·Journal of the National Cancer Institute·K Robin YabroffMartin L Brown
Sep 24, 2004·Cancer·Craig C Earle, Bridget A Neville
Sep 17, 2005·CA: a Cancer Journal for Clinicians·Barbara Hoffman

❮ Previous
Next ❯

Citations

Nov 5, 2009·Journal of General Internal Medicine·Susan HongPamela Ganschow
Nov 5, 2009·Journal of General Internal Medicine·Marie NorredamNancy L Keating
Sep 27, 2012·Journal of Cancer Survivorship : Research and Practice·K Robin YabroffKatherine S Virgo
May 9, 2012·Journal of Cancer Survivorship : Research and Practice·Lillian R MeachamAnn C Mertens
Sep 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul C NathanKevin C Oeffinger
Jun 6, 2009·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Kaan TunceliOzgur Tunceli
Jul 1, 2015·The Australian Journal of Rural Health·Kyung-Mee Choi
Jan 19, 2016·American Journal of Preventive Medicine·Donatus U EkwuemeJustin G Trogdon
Oct 26, 2010·Seminars in Oncology Nursing·Kathleen A GriffithMarguerite Russo
Dec 2, 2015·Journal of Cancer Survivorship : Research and Practice·Minjee Lee, Ramzi G Salloum
Oct 26, 2012·Cancer·Kathryn E WeaverL Douglas Case
Jun 4, 2014·Cancer·Scott E RegenbogenArden M Morris
Nov 23, 2015·American Journal of Preventive Medicine·Judith Lee Smith, Ingrid J Hall
Jul 22, 2014·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Bronwyn E FieldsJeri L Bigbee
Apr 30, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sapna KaulAnne C Kirchhoff
Aug 28, 2016·Cancer Epidemiology·Vinay K Cheruvu, S Cristina Oancea
Sep 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gery P GuyKatherine S Virgo
Feb 16, 2011·International Journal of Health Services : Planning, Administration, Evaluation·Tae Ho YoonHyeung-Keun Park
Jun 7, 2014·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Christopher J KingStephen B Thomas
Jan 2, 2018·Journal of Managed Care & Specialty Pharmacy·Min Jee LeeRamzi G Salloum
Sep 27, 2018·Journal of the National Cancer Institute·Janet S de MoorCathy J Bradley
Mar 11, 2016·Journal of Psychosocial Oncology·Huilin ChengKaris K F Cheng
Apr 9, 2021·American Society of Clinical Oncology Educational Book·Raymond U OsarogiagbonSanjay Goel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Christopher J LongoA Paul Williams
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Cathy J Bradley
© 2022 Meta ULC. All rights reserved